Back to Search
Start Over
Association between Inhaled Corticosteroid Use and SARS-CoV-2 Infection: A Nationwide Population-Based Study in South Korea
- Source :
- Tuberculosis and Respiratory Diseases, Tuberculosis and Respiratory Diseases, Vol 85, Iss 1, Pp 80-88 (2022)
- Publication Year :
- 2022
- Publisher :
- The Korean Academy of Tuberculosis and Respiratory Diseases, 2022.
-
Abstract
- Background: Although it is known that inhaled corticosteroid (ICS) use may increase the risk of respiratory infection, its influence on the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unknown. Thus, the aim of this study was to investigate the association between ICS use and the positivity of SARS-CoV-2 infection among patients with chronic respiratory diseases.Methods: Nationwide data of 44,968 individuals with chronic respiratory diseases tested for SARS-CoV-2 until May 15, 2021 were obtained from the Ministry of Health and Welfare and Health Insurance Review and Assessment Service in Korea. The positivity of SARS-CoV-2 infection was retrospectively analysed according to the prescription, type, and dose of ICS taken one year before SARS-CoV-2 test.Results: Among 44,968 individuals tested, 931 (2.1%) were positive for SARS-CoV-2. A total of 7,019 patients (15.6%) were prescribed ICS one year prior to being tested for SARS-CoV-2. Low, medium, and high doses of ICS were prescribed in 7.5%, 1.6%, and 6.5% of total cases, respectively. Among types of ICS, budesonide, fluticasone, beclomethasone, and ciclesonide were prescribed in 3.7%, 8.9%, 2.3%, and 0.6% of total cases, respectively. A multivariate analysis showed no significant increase in infection with ICS use (odds ratio, 0.84; 95% confidence interval, 0.66–1.03). Moreover, there were no associations between the positivity of infection and the dose or type of ICS prescribed.Conclusion: Prior ICS use did not increase the positivity for SARS-CoV-2 infection. Moreover, different doses or types of ICS did not affect this positivity.
- Subjects :
- Risk
Pulmonary and Respiratory Medicine
Budesonide
medicine.medical_specialty
Multivariate analysis
medicine.drug_class
Ciclesonide
Diseases of the respiratory system
chemistry.chemical_compound
Internal medicine
Medicine
Respiratory system
Medical prescription
Fluticasone
RC705-779
business.industry
Pulmonary Infection
Respiratory infection
Chronic Respiratory Diseases
Severe Acute Respiratory Syndrome Coronavirus 2
Infectious Diseases
chemistry
Corticosteroid
Original Article
business
Inhaled Corticosteroid
medicine.drug
Subjects
Details
- ISSN :
- 20056184 and 17383536
- Volume :
- 85
- Database :
- OpenAIRE
- Journal :
- Tuberculosis and Respiratory Diseases
- Accession number :
- edsair.doi.dedup.....eea8c8bff65732724f6c594b6f04492f